Health news
Health news top Health news

   Login  |  Register    
Health News Make AMN Your Home PageDiscussion BoardsAdvanced Search ToolMedical RSS/XML News FeedHealth news
  You are here : Health.am > Health Centers > Drug News - Flu -
FDA approves Roche’s low dose Tamiflu for children FDA approves Roche’s low dose Tamiflu for children

FDA approves Roche’s low dose Tamiflu for children

Drug News • • FluJul 04, 2007

Swiss drugmaker Roche Holding AG said on Monday that U.S. health regulators approved its Tamiflu influenza treatment at two lower doses for children in a form with a longer shelf life that could be an advantage for use in stockpiling against a flu pandemic.

The U.S. Food and Drug Administration approved Tamiflu capsules for sale at 30 milligram and 45 mg doses for the treatment and prevention of influenza types A and B in patients one year and older, Roche said.

The shelf life of the capsules is five years, the company said, considerably longer than that of the 24-month shelf life of the standard liquid suspension formulation.

Many countries are stockpiling the anti-viral drug with the hope that it will be able to lessen the effects of an influenza pandemic if and when one strikes.

The 30 mg and 45 mg capsules will be available nationwide and for government stockpiling in time for the 2007-2008 flu season, Roche said.

“Roche continues to take steps to facilitate the use of antivirals in pandemic preparedness and response,” Dominick Iacuzio, medical director at Roche, said in a statement.

“These lower dose capsules not only provide governments with a new option for pandemic stockpiling, but also give prescribing physicians an alternative for patients who prefer a capsule formulation,” he said.

Roche has received Tamiflu orders totaling 215 million treatment courses from more than 75 countries. It has also donated 5.1 million Tamiflu treatment courses to the World Health Organization to help contain any initial pandemic outbreak.

Roche said it has filled orders from the U.S. government and states for 43.7 million Tamiflu treatment courses so far.

Tamiflu will continue to be available in a 75 mg capsule for adults as well as liquid suspension formulation for children, the company said.

Provided by ArmMed Media

FDA approves Roche’s low dose Tamiflu for children Bookmark this! FDA approves Roche’s low dose Tamiflu for children

RELATED STORIES:


 Comments [ + Post Your Own

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]




We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.

All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

Please enter the word you see in the image below:


   [advanced search]   
What health info have you recently searched for online?
Disease or condition
Exercise or fitness
Diet, nutrition or vitamins
None of the above


Get free support - Headache Causes, Symptoms, Diagnosis, and Treatment on HeadacheCare.net


Health Centers







Diabetes

















Health news
  


Health Encyclopedia

Diseases & Conditions

Drugs & Medications

Health Tools

Health Tools



   Health newsletter

  





   Medical Links



   RSS/XML News Feed



   Feedback


Add to Yahoo RSS News Feed



Google Reader




Syndicate


This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information:
Verify here.




Activity key to a Dementia sufferer\’\s well-being at DementiaToday.net

hit counter